title: Long term response to erlotinib in a patient with recurrent vulvar carcinoma: Case report and review of literature.
abstract: ► We report a case of recurrent vulvar carcinoma with a good response to erlotinib. ► Treatment was well tolerated with no serious side effects. ► Further evaluation of this new therapeutic approach may be warranted.
authors.affiliation: Department of Medical Oncology, Hôpital René Huguenin (Institut Curie), 35 rue Dailly 92210 Saint-Cloud, France.
authors.forename: Hanane
authors.initials: H
authors.lastname: Inrhaoun
authors.affiliation: Department of Medical Oncology, National Institute of Oncology, Allal Elfassi Street, Rabat, Morocco.
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Elghissassi
authors.affiliation: Department of Medical Oncology, Hôpital René Huguenin (Institut Curie), 35 rue Dailly 92210 Saint-Cloud, France.
authors.forename: Maya
authors.initials: M
authors.lastname: Gutierrez
authors.affiliation: Department of Medical Oncology, Hôpital René Huguenin (Institut Curie), 35 rue Dailly 92210 Saint-Cloud, France.
authors.forename: Etienne
authors.initials: E
authors.lastname: Brain
authors.affiliation: Department of Medical Oncology, National Institute of Oncology, Allal Elfassi Street, Rabat, Morocco.
authors.forename: Hassan
authors.initials: H
authors.lastname: Errihani
keywords: EGFR; Erlotinib; Vulvar carcinoma